A

PriceAchilles Therapeutics

ACHL

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Historical stock price chart and annual return over the past years

-91%

4 years

% Total

ACHL
-46%

4 years

Annual Return

ACHL